Key market opportunities in AI-generated voice therapy include the rising demand for remote and personalized solutions, the ...
Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback